Skip to main content
Log in

Kardiovaskuläre Komorbiditäten häufig übersehen

Interaktion Lungenüberblähung und Herzfunktion

  • Fortbildung
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

1

© P. Alter

2

© P. Alter

3

© mit freundlicher Genehmigung aus [3]

Literatur

  1. Vanfleteren LE, Spruit MA, Groenen M et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728-35

  2. Alter P, Vogelmeier CF, Jörres RA. COPD und kardiovskuläre Komorbiditäten. PneumoNews. 2018;10(2):27-31

  3. Alter P, Mayerhofer BA, Kahnert K et al. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort. Int J Chron Obstruct Pulmon Dis. 2019;14:2163-72

  4. Watz H, Waschki B, Meyer T et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010;138(1):32-8

  5. Kawut SM, Poor HD, Parikh MA et al. Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study. J Am Coll Cardiol. 2014;64(19):2000-9

  6. Alter P, Jorres RA, Watz H et al. Left ventricular volume and wall stress are linked to lung function impairment in COPD. Int J Cardiol. 2018;261:172-8

  7. Alter P, van de Sand K, Nell C et al. Airflow limitation in COPD is associated with increased left ventricular wall stress in coincident heart failure. Respir Med. 2015;109(9):1131-7.

  8. Alter P, Watz H, Kahnert K et al. Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir Med. 2018;137:14-22

  9. Stone IS, Barnes NC, James WY et al. Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2016;193(7):717-26

  10. Hohlfeld JM, Vogel-Claussen J, Biller H et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med. 2018;6(5):368-78

  11. Vogel-Claussen J, Schonfeld CO, Kaireit TF et al. Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial. Am J Respir Crit Care Med. 2019;199(9):1086-96

  12. Alter P, Watz H, Kahnert K et al. Effects of airway obstruction and hyperinflation on electrocardiografic axes in COPD. Respir Res. 2019;20(1):61

  13. Alter P, Orszag J, Kellerer C et al. Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: Results from COSYCONET. ERJ Open Res. 2020;6(3):00092-2020. https://doi.org/10.1183/23120541.00092-2020.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Alter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alter, P., Vogelmeier, C. & Jörres, R. Interaktion Lungenüberblähung und Herzfunktion. Pneumo News 12, 28–32 (2020). https://doi.org/10.1007/s15033-020-1901-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-020-1901-7

Navigation